Industrials
Smiths Group plc(SMGZY)
Live Price
Offline$34.57
+0.64% today
1Y Change
+10.06%
Window
Jun 23, 2025 โ Jun 1, 2026
- Market Cap
- $7.67B
- Revenue Growth
- -6.9%
- EPS Growth
- +12.5%
- Dividend Yield
- 1.8%
Coverage: 236 bars ยท Jun 23, 2025 โ Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Smiths Group plc (SMGZY) is a Industrials stock with a market cap of $7.67B and listed on OTC. The stock last traded around $34.57 and up 10.1% across the available one-year price window (Jun 23, 2025 โ Jun 1, 2026). Baseline metrics include revenue growth of -6.9%, EPS growth of +12.5%, a dividend yield of 1.8%. What stands out right now is revenue -6.9%, EPS +12.5%, free cash flow +15.7% with operating margin 15.2% and ROIC 7.5%. The dividend is present but secondary, with a yield around 1.8%. Valuation already assumes a fairly strong business story at P/E 32.4 and price/sales 3.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SMGZY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-6.9% vs +3.6% peer median
Operating Margin
Near sector median
+15.2% vs +16.9% peer median
P/E
Below sector median
32.4 vs 36.7 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Mar 20, 2026 with an EPS surprise of +6.2% and a revenue surprise of -3.8%.
The operating picture looks softer than before
Revenue is at -6.9% and EPS is at +12.5%, with operating margin around 15.2%.
The next real check-in already has a date
The next earnings event is scheduled for Sep 29, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +2.7% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 20, 2026 | +6.2% | +6.9% | +8.1% | +24.8% |
2025 Sep 22, 2025 | -43.4% | -3.8% | -4.6% | +1.8% |
2025 Mar 25, 2025 | -12.5% | +2.3% | +4.5% | +7.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SMGZY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SMGZY Max Drawdown
-24.28%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SMGZY and SPY.
Company Overview
Smiths Group plc
Other OTC
Smiths Group plc operates as a technology company serving the medical technology, security and defense, general industrial, energy, and space and aerospace markets worldwide. It operates through John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect, and Smiths Medical divisions. The John Crane division offers mechanical seals, seal support systems, hydrodynamic bearings, packing materials, power transmission couplings, and specialized filtration systems. The Smiths Detection division provides sensors and systems that detect and identify explosives, narcotics, weapons, chemical agents, biohazards, and contraband. The Flex-Tek division offers engineered components that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. The Smiths Interconnect division provides specialized electronic and radio frequency board-level and waveguide devices, connectors, cables, test sockets, and sub-systems for applications in the security and defense, medical, general industrial, and space and aerospace markets. The Smiths Medical division offers infusion systems, vascular access, patient airway, and temperature management equipment products; and specialised devices in areas of diagnostic and emergency patient transport. The company was formerly known as Smiths Industries and changed its name to Smiths Group plc in 2000. Smiths Group plc was founded in 1851 and is headquartered in London, the United Kingdom.
- Leadership
- Roland Henry Clyne Carter
- IPO Date
- Nov 2, 2010
- Employees
- 15.8k
- Street Address
- 11-12 St James's Square
- Mailing
- London, SW1Y 4LB
- Region
- London, GB
- Reporting Currency
- USD
- Investor Line
- 44 20 7004 1600
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 32.4
- EV/EBITDA
- 23.7
- Price/Sales
- 3.5
- Price/Book
- 4.9
Growth
- Revenue
- -6.9%
- EPS
- +12.5%
- Free Cash Flow
- +15.7%
Profitability
- Gross Margin
- 9.5%
- Operating Margin
- 15.2%
- Net Margin
- 11.4%
- ROE
- 13.7%
- ROIC
- 7.5%
Balance Sheet
- Debt/Equity
- 0.73
- Current Ratio
- 3.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.